Stock 141A TRIAL HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Trial Holdings Inc.

Equities

141A

JP3635490000

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-05-08 am EDT 		5-day change 1st Jan Change
2,816 JPY +0.36% Intraday chart for Trial Holdings Inc. -1.33% 0.00%
May. 06 Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints MT
May. 06 UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints
MT
UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT
MT
WHO Selects International Nonproprietary Name for Percheron Therapeutics' Drug Candidate ATL1102
MT
Former Trump aide testifies he told her to deny affair
RE
US Equity Markets Close Higher Friday Following Weak Jobs Report
MT
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
MT
Prosecutors seek trial for Italian minister over alleged fraud
RE
Google trial wraps up as judge weighs landmark US antitrust claims
RE
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
MT
AEON Biopharma Shares Slump Pre-Bell After Failed Chronic Migraine Phase 2 Trial
MT
Kelso raises stake in NCC; Transense joins project
AN
Arrowhead Nets $50 Milestone Payment from Royalty Pharma After Completion of Enrollment in Trial of Cardiovascular Drug
MT
Indian wrestlers upset as Modi's party fields controversial lawmaker's son in polls
RE
Ondine Biomedical shares rise on fundraise to advance Steriwave
AN
Ondine Biomedical to Raise GBP3 Million Via Placing, Subscription
MT
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
RE
Google faces second day of closing arguments in US antitrust trial
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 141A Stock
  4. News Trial Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW